-
Successful Treatment of Extensively Drug-Resistant Acinetobacter baumannii Intracranial Infection with Meropenem and Cefoperazone Sodium Sulbactam: A Case Report
04 Apr 2025 11:24 GMT
… combined with vancomycin was empirically used for anti-infective treatment. XDR … Injection for the Treatment of Extensively Drug-Resistant Acinetobacter baumannii … colistin for the treatment of extensively drug resistant Acinetobacter baumannii …
-
Comparison of Vancomycin and Linezolid for Staphylococcal CNS Infections
03 Apr 2025 15:24 GMT
… a summary of “Vancomycin versus linezolid for treatment of staphylococcal-associated … regression model, vancomycin was not significantly associated with treatment failure (aHR … analysis showed an association between vancomycin and treatment failure (HR 3.28 …
-
Shortage of medicines continues to plague Delhi government hospitals
02 Apr 2025 23:04 GMT
… antibiotics like Vancomycin. “Even the most basic pain relieving medicine like Diclofenac … gastroenterology care, doctors complain that of the essential drug list, medicines like Ecosprin … stroke and angina), Clopitab (for treatment of heart attack), as well …
-
Glenmark launches vancomycin hydrochloride for injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (single-dose vial)
01 Apr 2025 09:04 GMT
… led, global pharmaceutical company, announces the launch of vancomycin hydrochloride for … equivalent to the reference listed drug, vancomycin hydrochloride for injection USP, … our institutional portfolio.”
Glenmark Pharmaceuticals Ltd. is a research-led …
-
Glenmark launches antibacterial solution Vancomycin Hydrochloride in US
01 Apr 2025 08:47 GMT
… -based Glenmark Pharmaceuticals US-arm has launched Vancomycin Hydrochloride for … to the reference listed drug, of Mylan Laboratories and … the Indian drug maker will market its … single-dose vial of Vancomycin Hydrochloride injection and are …
-
Glenmark Pharmaceuticals launches generic formulation to treat bacterial infections
01 Apr 2025 06:56 GMT
Glenmark Pharmaceuticals Inc., USA on Tuesday announced the launch of Vancomycin Hydrochloride … equivalent to the reference listed drug, Vancomycin Hydrochloride for Injection USP, … period ending January 2025, the Vancomycin Hydrochloride for Injection USP, …
-
Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
01 Apr 2025 05:36 GMT
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Vancomycin Hydrochloride for … equivalent to the reference listed drug, Vancomycin Hydrochloride for Injection USP, … ."
Shares of Glenmark Pharmaceuticals Limited was last trading in …
-
Reduced fidaxomicin susceptibility may emerge during C. difficile treatment
31 Mar 2025 22:55 GMT
… susceptibility may emerge during treatment and could spread … at the Cleveland VA Medical Center, told Healio. … that all were susceptible to vancomycin, rifampin, moxifloxacin and … potential contributor to fidaxomicin treatment failure
For ore nformation …
-
Theriva™ Biologics Announces Positive Outcomes from the Second Meeting of the Independent Data Monitoring Committee for VIRAGE, the Company’s Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal…
31 Mar 2025 12:00 GMT
… population and the medications being studied. The … treatment (study days 1 and ~92 respectively). Primary endpoints for the trial … European Union Drug Regulating Authorities Clinical Trials Database (EudraCT … such as VRE (vancomycin resistant Enterococci) and …
-
Silent Threat: The Overlooked Infection Crisis in Dialysis Patients
03 Apr 2025 21:46 GMT
… preventive actions in their treatment plans.5 The … colonized with MRSA or vancomycin-resistant Enterococci), and additional … the multidose medication is brought to the patient treatment area, … Dedicated separate rooms for treatment of patients infected with …